XML 25 R11.htm IDEA: XBRL DOCUMENT
v3.22.2.2

REVENUES | 6 Months Ended
--- | ---
Jun. 30, 2022
REVENUES |
REVENUES | NOTE 4 – REVENUES ​ The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended June 30, | ​ | Six Months Ended June 30,
(U.S. dollars in thousands) |  | 2022 |  | 2021 | ​ | 2022 |  | 2021
Pfizer | ​ | $ | 3,382 | ​ | $ | 2,237 | ​ | $ | 6,738 | ​ | $ | 6,748
Brazil | ​ | $ | - | ​ | $ | 988 | ​ | $ | 5,454 | ​ | $ | 988
Chiesi | ​ | $ | - | ​ | $ | 18 | ​ | $ | 218 | ​ | $ | 18
Total revenues from selling goods | ​ | $ | 3,382 | ​ | $ | 3,243 | ​ | $ | 12,410 | ​ | $ | 7,754
Revenues from license and R&D services | ​ | $ | 5,371 | ​ | $ | 3,184 | ​ | $ | 12,428 | ​ | $ | 9,993
​

X
- Definition The entire disclosure pertaining to revenue. + References No definition available. + Details
Name: | plx_RevenueDisclosureTextBlock
Namespace Prefix: | plx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration